Taken together, results support the concept that an impairment of PTP1B degradation could be one of the mechanisms underlying zinc deficiency-mediated deactivation of the JAK2/STAT3 signaling pathway during early brain development. The gene discussed is JAK2; the disease is Zinc deficiency.